SI-BONE Corp (SIBN): Utang-utang marang kapitalisasi buku

Tandha merek SI-BONE Inc (SIBN)

This price chart helps assess the impact of risks associated with physician adoption of technologies and insurance reimbursements on SI-BONE, Inc. (SIBN) quotes. SI-BONE, Inc. (SIBN) specializes in pelvic pain therapy, leveraging the uniqueness of its solutions and the expansion of insurance coverage. High product margins, given the current 0.24 metric, are partially offset by surgeon training costs and the expansion of the sales force.

SIBN - Utang-utang marang aset resik SI-BONE Medical ing rentang 04.07.2022 - 27.10.2026
Produk asli SI-BONE Inc

SI-BONE, Inc. (SIBN) is betting on organic demand growth and eschewing mergers, making financial stability a critical development factor. By analyzing the ratio of borrowed funds to balance sheet capitalization, investors can assess the proportion of debt within the company's equity structure, enabling real-time monitoring of the debt load and resource management discipline.

Pesaing SI-BONE, Inc.

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|ESTA - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku BBNX|IRADIMED Corp (IRMD) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Embecta Inc. (EMBC)|Rasio utang marang nilai buku Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Utang marang nilai buku|Rasio utang marang aset resik OFIX (orthofix.com)|Bioventus - Rasio utang marang kapitalisasi buku|Utang marang nilai buku OrthoPediatrics Corp KIDS|TMCI (Treace Medical) - Utang-utang marang kapitalisasi buku|SRTA - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Carlsmed Inc|rxsight.com (RXST) - Rasio utang marang nilai buku|CLPT: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Stereotaxis Inc|Utang-utang marang kapitalisasi buku STIM (NeuroStar)|Utang marang nilai buku Sight Sciences Inc (SGHT)|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Utang-utang marang kapitalisasi buku|NSPR - Rasio utang marang kapitalisasi buku|Jin Medical International (ZJYL) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku vivani.com VANI|Xtant Medical (XTNT) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku NMTC (NeuroOne Medical Technologies)|Utang-utang marang nilai buku MODD|MYO: Rasio utang marang kapitalisasi buku|Utang marang aset resik Envoy Medical Inc. COCH|Utang marang nilai buku VVOS (Vivos Therapeutics, Inc)|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|Utang-utang marang kapitalisasi buku SINT (SINTX Technologies)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO